PROMETHAZINE VC W Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Promethazine Vc W, and when can generic versions of Promethazine Vc W launch?
Promethazine Vc W is a drug marketed by Cenci and Wockhardt and is included in two NDAs.
The generic ingredient in PROMETHAZINE VC W is codeine phosphate; phenylephrine hydrochloride; promethazine hydrochloride. There are nineteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the codeine phosphate; phenylephrine hydrochloride; promethazine hydrochloride profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for PROMETHAZINE VC W?
- What are the global sales for PROMETHAZINE VC W?
- What is Average Wholesale Price for PROMETHAZINE VC W?
Summary for PROMETHAZINE VC W
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 2 |
| DailyMed Link: | PROMETHAZINE VC W at DailyMed |
US Patents and Regulatory Information for PROMETHAZINE VC W
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cenci | PROMETHAZINE VC W/ CODEINE | codeine phosphate; phenylephrine hydrochloride; promethazine hydrochloride | SYRUP;ORAL | 088816-001 | Nov 22, 1985 | DISCN | No | No | ⤷ Get Started Free | ⤷ Get Started Free | ⤷ Get Started Free | ||||
| Wockhardt | PROMETHAZINE VC W/ CODEINE | codeine phosphate; phenylephrine hydrochloride; promethazine hydrochloride | SYRUP;ORAL | 088896-001 | Jan 4, 1985 | DISCN | No | No | ⤷ Get Started Free | ⤷ Get Started Free | ⤷ Get Started Free | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
